)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
Bacil Pharma
Bacil Pharma (524516) investor relations material
Bacil Pharma Q1 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 26/27 earnings summary11 Aug, 2026
Executive summary
Board approved unaudited financial results for the quarter ended 30th June 2026, with results reviewed by the Audit Committee and subject to a limited review by statutory auditors.
Financial statements prepared in compliance with Indian Accounting Standards (Ind AS) and SEBI regulations.
Financial highlights
Revenue from operations for the quarter was ₹8.91 lakhs, unchanged year-over-year and down from ₹11.34 lakhs in the previous quarter.
Total expenses for the quarter were ₹2.27 lakhs, significantly lower than ₹7.45 lakhs in the previous quarter and ₹10.90 lakhs in the same quarter last year.
Profit before tax was ₹6.64 lakhs, up from ₹3.89 lakhs in the previous quarter and a loss of ₹89.40 lakhs in the same quarter last year.
Profit after tax was ₹30.12 lakhs, compared to a loss of ₹164.14 lakhs in the previous quarter and a profit of ₹66.90 lakhs in the same quarter last year.
Other comprehensive income for the quarter was ₹31.73 lakhs, compared to a loss of ₹226.30 lakhs in the previous quarter.
Key financial ratios and metrics
Basic and diluted EPS for the quarter were ₹0.22, compared to ₹0.44 in the previous quarter and ₹0.48 in the same quarter last year.
Paid-up equity share capital stood at ₹1,397.03 lakhs.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Bacil Pharma
- FY26 saw higher revenue but a net loss due to investment valuation, with operations yet to restart.524516
Q4 25/26 - Quarterly net profit rose to ₹3.92 lakhs with improved revenue and clean auditor review.524516Q3 25/26
- Sharp drop in revenue and profit, with auditors issuing a disclaimer due to major uncertainties.524516Q2 25/26
- Profit rebounded sharply in Q1 FY26, but auditor raised concerns over fund application.524516Q1 25/26
- Q2 FY25 saw a sharp turnaround to profit and revenue growth, but loan recoverability remains uncertain.524516Q2 24/25
- Quarterly loss before tax, but profit after OCI; auditor flags loan recoverability concerns.524516Q1 24/25
- FY25 saw significant revenue and profit growth, but loan recoverability remains a concern.524516Q4 24/25
- Net loss in Q3 FY25, no core revenue, and auditor flags loan recoverability concerns.524516Q3 24/25
Next Bacil Pharma earnings date
Q2 26/2713 Nov, 2026
Bacil Pharma
Next Bacil Pharma earnings date
Q2 26/2713 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage